JVS-vascular insights最新文献

{"title":"Readability of Society for Vascular Surgery patient education flyers does not meet national standards","authors":"Arnav Mahajan MB ,&nbsp;Pooja Podugu MD ,&nbsp;Ali Mansoor Kara MD ,&nbsp;Ariadna Marrero MD ,&nbsp;Ramiro Cadena MD ,&nbsp;Garietta Falls-Beddies MD","doi":"10.1016/j.jvsvi.2025.100269","DOIUrl":"10.1016/j.jvsvi.2025.100269","url":null,"abstract":"<div><h3>Objective</h3><div>The Society for Vascular Surgery (SVS) launched the Your Vascular Health microsite to enhance public awareness of vascular disease through educational content. The effectiveness of such materials depends on adherence to national recommendations that patient-facing content be written at a sixth-grade reading level to ensure accessibility for the median United States adult. With evidence suggesting that patient education materials frequently exceed recommended reading levels across medical disciplines, we aimed to assess the readability of all SVS Your Vascular Health patient education flyers.</div></div><div><h3>Methods</h3><div>We analyzed all publicly available SVS Your Vascular Health flyers using four validated readability metrics: Flesch-Kincaid Grade Level (FKGL), Simple Measure of Gobbledygook (SMOG), Automated Readability Index (ARI), and Flesch Reading Ease (FRE). FKGL, SMOG, and ARI scores (which correlate with grade level) &lt;6.0 and FRE scores &gt;80 indicate sixth-grade reading level compliance. Estimated reading times were calculated at 200 words per minute, and descriptive statistics were reported.</div></div><div><h3>Results</h3><div>None of the 15 reviewed flyers met the recommended sixth-grade readability threshold. Mean scores were FKGL 9.9 (standard deviation [SD], 1.7), SMOG 12.1 (SD, 1.5), ARI 9.4 (SD, 1.8), and FRE 43.8 (SD, 10.6). The mean reading time was 3 minutes (range, 2-5 minutes). The most readable flyer was on thoracic outlet syndrome, which ranged from seventh- to eleventh-grade reading level with different measures (FKGL 7.6, SMOG 11.0, ARI 7.4), whereas the least readable was on Cerebrovascular Disease at a fourteenth- to fifteenth-grade reading level (FKGL 13.9, SMOG 15.0, ARI 14.1).</div></div><div><h3>Conclusions</h3><div>The SVS Your Vascular Health patient education flyers fail to meet established health literacy standards despite their public awareness mission. Materials average nearly a tenth-grade reading level—four grades above national recommendations. These findings raise concerns about accessibility and equity in vascular disease education efforts, particularly for vulnerable populations with limited health literacy. Improving readability should become a central priority in vascular public health outreach, with further research needed to assess whether these materials effectively reach and engage intended audiences.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100269"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From coast to coast: Showcasing Canadian innovation in vascular surgery","authors":"Laura M. Drudi MD ,&nbsp;Samuel Jessula MD","doi":"10.1016/j.jvsvi.2025.100288","DOIUrl":"10.1016/j.jvsvi.2025.100288","url":null,"abstract":"","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100288"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Study design of the GORE VIAFORT Vascular Stent trials for the treatment of symptomatic inferior vena cava obstruction with or without iliofemoral obstruction and unilateral iliofemoral obstruction","authors":"Kathleen Gibson MD ,&nbsp;Kush Desai MD ,&nbsp;Gabe Donatell MS ,&nbsp;Maryrose Bisagna Smith MPH ,&nbsp;Rizwan Afzal MS ,&nbsp;Stephen Black MD","doi":"10.1016/j.jvsvi.2025.100295","DOIUrl":"10.1016/j.jvsvi.2025.100295","url":null,"abstract":"<div><h3>Objective</h3><div>Ambulatory venous hypertension secondary to chronic inferior vena cava (IVC) and iliofemoral obstruction can have considerable impact on patient quality of life, including pain, edema, venous ulceration, and exercise intolerance. To date, there are no venous stents available in the United States specifically designed to treat iliocaval obstruction. The GORE VIAFORT Vascular Stent clinical trials investigate the safety and effectiveness of a novel venous stent developed for the treatment of symptomatic IVC obstruction, with or without iliofemoral obstruction, as well as unilateral symptomatic iliofemoral venous obstruction.</div></div><div><h3>Methods</h3><div>Two prospective, nonrandomized, multicenter, single-armed clinical studies are being conducted at 34 clinical sites. The iliocaval study enrolled 89 patients in the United States, Europe, Australia, and New Zealand, with an additional 23 patients enrolled globally for regulatory purposes, for a total of 112 patients. Its primary end point is a composite measure that includes primary patency and freedom from stent embolization/migration at 12 months, as well as 30-day freedom from clinically significant pulmonary embolism and device- or procedure-related events (eg, death, major bleeding, or vascular injury requiring surgical or endovascular intervention). The iliofemoral study aims to enroll up to 165 patients in the United States. Its primary composite safety end point consists of freedom from stent embolization/migration at 12 months, as well as 30-day freedom from clinically significant pulmonary embolism and device- or procedure-related events (eg, death, major bleeding, and vascular injury requiring surgical or endovascular intervention). The distinct primary efficacy end point is primary patency through 12 months. Secondary end points for both studies include technical, lesion, and procedural success; primary and secondary patency; clinically driven target lesion revascularization; and device fractures through the 60-month follow-up, stent embolization through 12-month follow-up, and individual device- or procedure-related events through 30 days. Quality of life scores assessed through 60 months include revised Venous Clinical Severity Scale (rVCSS), rVCSS pain score, VEINES, Villalta, and EQ-5D-5L. The primary end points and the secondary end point of improvement in rVCSS pain score at 12 months will undergo formal hypothesis testing in both studies. All additional secondary end points will be summarized descriptively.</div></div><div><h3>Conclusions</h3><div>The GORE VIAFORT Vascular Stent clinical trials are designed to evaluate the safety and efficacy of the unique GORE VIABAHN Venous Stent for the treatment of IVC and iliofemoral occlusive disease.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100295"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A narrative review exploring the association between hypothyroidism and thoracic aortic diseases","authors":"Mohammad Hamzah BS ,&nbsp;Fatima Al-Maaz BS ,&nbsp;Ahmad Chalhoub BS ,&nbsp;Rita Nemr MD","doi":"10.1016/j.jvsvi.2025.100246","DOIUrl":"10.1016/j.jvsvi.2025.100246","url":null,"abstract":"<div><h3>Background</h3><div>Thoracic aortic aneurysms (TAA) and aortic dissections (AD) are recognized as one of the leading causes of death in developed countries. Although mortality decreases if at-risk individuals are diagnosed early, on thorough screening, many fail to seek the proper preventive interventions timely. Genetic predisposition, smoking, and hypertension are well-known risk factors for highly lethal aortic aneurysmal rupture or dissection. Hypothyroidism has also been described extensively in the literature as a possible risk factor directly related to the origin of TAA and dissection. Numerous studies have proposed a pathophysiological role for hypothyroidism in the development of TAA and AD, although this role is still not fully understood. This scoping review sought human and animal studies to examine the relationship between hypothyroidism and thoracic aortic diseases.</div></div><div><h3>Methods</h3><div>A search in PubMed, Web of Science, and Scopus using the terms “aortic dissection,” “aorta,” “aortic aneurysm,” and “hypothyroidism” yielded 907 articles, although only 9 were relevant to this study topic and criteria.</div></div><div><h3>Results</h3><div>The included articles discuss thoracic aortic diseases as potential risk factors for TAA and dissection. A low thyroid hormone level might be a negative prognostic indicator after acute AD.</div></div><div><h3>Conclusions</h3><div>Establishing a link between hypothyroidism and thoracic aortic diseases could improve clinical practice through the development of screening strategies for thyroid function in patients with thoracic aortic diseases, thereby reducing postoperative mortality rates.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100246"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144366209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Artificial intelligence-powered remote monitoring for lower extremity wound management: A randomized controlled trial protocol","authors":"Y.H. Andrew Wu MD ,&nbsp;Alana C. Keegan MD ,&nbsp;Midori P. Starks White MD ,&nbsp;Sanuja Bose MD, MPH ,&nbsp;Sherry G. Leung BA ,&nbsp;Ronald Sherman DPM ,&nbsp;Christopher J. Abularrage MD ,&nbsp;Elizabeth Selvin PhD, MPH ,&nbsp;Caitlin W. Hicks MD, MS","doi":"10.1016/j.jvsvi.2025.100279","DOIUrl":"10.1016/j.jvsvi.2025.100279","url":null,"abstract":"<div><h3>Background</h3><div>Lower extremity wounds associated with diabetes are a serious global health issue, with diabetic foot ulcers affecting 12% to 25% of adults with diabetes and accounting for 80% to 90% of all lower extremity amputations in the United States. Comprehensive in-person care for lower extremity wounds is important but can be burdensome for patients and costly for health care systems. A cost-effective telehealth model using a smartphone-integrated digital application that remotely analyzes wound status with machine learning algorithms in real time could make lower extremity wounds care more accessible to patients. This trial aims to determine if artificial intelligence (AI)-powered digital remote monitoring is a feasible, patient-centered solution for remote wound monitoring and management compared with standard in-person visits.</div></div><div><h3>Methods</h3><div>We will conduct a nonblinded randomized control trial of 120 patients with active lower extremity wounds treated in the Johns Hopkins Hospital Multidisciplinary Diabetic Foot and Wound Clinic in Baltimore, Maryland (ClinicalTrials.gov: <span><span>NCT05579743</span><svg><path></path></svg></span>). Participants will be randomly assigned 1:1 to receive wound care monitoring using AI-powered remote wound monitoring technology (Healthy.io) or standard in-person monitoring for 12 weeks. The primary aim is to establish the feasibility of a novel remote patient-centered monitoring program for the surveillance and monitoring of lower extremity wounds. Secondary aims include evaluating patient and provider satisfaction with remote wound monitoring technology compared with standard in-person monitoring and generating pilot data on wound healing times and major amputation rates in patients who are monitored remotely compared with patients treated with the standard of care.</div></div><div><h3>Conclusions</h3><div>This trial will determine whether AI-powered remote digital monitoring is feasible and acceptable as an alternative to standard in-person monitoring for the monitoring and management of patients with active lower extremity wounds.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100279"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New horizons in abdominal aortic aneurysm management through customized endografts","authors":"Christian Tague MD","doi":"10.1016/j.jvsvi.2025.100256","DOIUrl":"10.1016/j.jvsvi.2025.100256","url":null,"abstract":"","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100256"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144589262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A qualitative study exploring the acceptability of the TEXTPAD telehealth and virtual supervised exercise intervention and trial for patients with peripheral arterial disease living in socioeconomically disadvantaged areas","authors":"Maddey Patterson MPH ,&nbsp;Letitia Sermin-Reed MSc ,&nbsp;James Prentis MBBS ,&nbsp;Arathi Radhakrishnan MBBS ,&nbsp;Eileen Kaner PhD ,&nbsp;Sandip Nandhra MBBS ,&nbsp;Maisie Rowland BSc ,&nbsp;Gabriel Cucato PhD ,&nbsp;Mackenzie Fong PhD","doi":"10.1016/j.jvsvi.2024.100175","DOIUrl":"10.1016/j.jvsvi.2024.100175","url":null,"abstract":"<div><h3>Background</h3><div>UK clinical guidelines recommend supervised exercise training and support for health behavior change for patients with peripheral arterial disease (PAD). Despite this, supervised exercise programs are largely unavailable and unfunded across the UK. Remote, virtual support may overcome some barriers to attending facilities in person experienced by PAD patients, such as poor mobility and financial cost. The TEXTPAD pilot randomized controlled trial investigated the impact of the 12-week TEXTPAD intervention that involved weekly phone calls for behavioral counselling and twice-weekly virtual, supervised exercise sessions. Both TEXTPAD and control group participants were encouraged to engage in an unsupervised walking program and were provided with an activity tracker. This qualitative study aimed to explore participants' acceptance of the TEXTPAD and unsupervised walking programs and trial procedures.</div></div><div><h3>Methods</h3><div>Participants were recruited from the vascular department of Newcastle-upon-Tyne Hospitals Trust. Eligibility for the pilot randomized controlled trial included age ≥40 years, a diagnosis of PAD, and living in an area in the lowest 30% of super output area based on the Office for National Statistics. Interview participants were sampled purposively based on study group allocation. A focus group was conducted with three health improvement practitioners who delivered the TEXTPAD intervention. Interview and focus group audio recordings were transcribed verbatim and thematic analysis was applied to data.</div></div><div><h3>Results</h3><div>A total of 18 participants were interviewed, comprising 9 participants each in the TEXTPAD and control groups (mean age, 66.2 years). Fifteen patients were male and three were female. Overall, the TEXTPAD and walking programs were highly acceptable to and positively perceived by participants. Some participants were not confident in using the various aspects of technology needed to engage in the TEXTPAD and walking programs and sought support from family, friends, or practitioners. TEXTPAD participants wanted more interaction with other participants to share experiences, advice, and information (theme 1). Participants in both groups perceived a range of benefits to their health and well-being (theme 2) and considered the study procedures to be acceptable and not overly burdensome (theme 3).</div></div><div><h3>Conclusions</h3><div>Providing exercise training and behavioral counselling virtually using digital technologies to people with PAD from lower socioeconomic backgrounds can be considered as an acceptable way to deliver care. However, people who have poorer digital skills must be provided with adequate support to use the technologies needed to engage with these virtual interventions. Enabling intervention participants to interact with each other would help to nurture social support which was perceived to be lacking in the current program.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100175"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143105157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Protocol for a randomized controlled trial of transdermal continuous oxygen therapy for surgical site wound healing after lower extremity revascularization","authors":"Khanjan Nagarsheth MD ,&nbsp;Georges Jreij MD ,&nbsp;Eleanor Dunlap DNP ,&nbsp;Shannon Hawkins DNP ,&nbsp;Rachel White BSN ,&nbsp;Areck Ucuzian MD, PhD ,&nbsp;Brajesh K. Lal MD","doi":"10.1016/j.jvsvi.2025.100236","DOIUrl":"10.1016/j.jvsvi.2025.100236","url":null,"abstract":"<div><h3>Objective</h3><div>Patients undergoing vascular surgery are at increased risk of poor wound healing due to ischemia and their underlying comorbidities. Following lower extremity revascularization, 40% to 50% of patients experience non-healing wounds that persist for months despite functional bypass grafts. Additionally, surgical site infections (SSIs) in these patients can lead to sepsis, disability, and limb loss. SSI rates are reported between 5% and 10% and as high as 32% for infrainguinal incisions. Supplemental systemic oxygen therapy has shown promise in improving wound healing and reducing SSIs. An emerging alternative is transdermal continuous oxygen therapy (TCOT), which delivers oxygen directly to the wound, thereby avoiding systemic effects of oxygen and simplifying the logistics of oxygen delivery. TCOT has demonstrated faster wound healing and lower infection rates compared with standard of care wound therapy in preliminary studies. We propose a randomized trial to provide level one evidence on the effectiveness of TCOT in improving incisional healing and reducing SSI rates in vascular surgery patients.</div></div><div><h3>Methods</h3><div>This randomized controlled trial will enroll 100 participants aged 18 to 90 years undergoing elective lower extremity arterial revascularization at the University of Maryland Medical Center and Baltimore VA Medical Center. Participants will be randomized 1:1 to receive either TCOT with control dressing, or control dressing alone. The investigational device, EPIFLO, will be used to deliver continuous oxygen to the wound via a semi-occlusive dressing for up to 28 days. The primary endpoint is the percent wound closure rate at 4 weeks, assessed using the Bates-Jensen Wound Assessment Tool. The secondary endpoint is SSI incidence at 90 days, evaluated with the Szilagyi classification. Participants will attend five follow-up visits, during which wound healing, SSIs, and adverse events will be recorded. A centralized randomization system will ensure balanced allocation, and blinded evaluators will assess wound images to reduce bias. Statistical analysis will include mixed models for repeated measures and Barnard’s test for SSI rates.</div></div><div><h3>Conclusions</h3><div>This study will provide level one evidence on the efficacy of TCOT in improving wound healing and preventing SSIs in vascular surgery patients.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100236"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Global trends and insights in vascular surgery research from 2000 to 2023","authors":"Arshia P. Javidan MD, MSc ,&nbsp;Polycronis P. Akouris BMSc, MSc ,&nbsp;Kaan Y. Balta BHSC, MBDc ,&nbsp;Wafa Baqri BSc ,&nbsp;Leslie Summers DeLuca PhD ,&nbsp;Ahmed Kayssi MD, MSC, MPH","doi":"10.1016/j.jvsvi.2025.100184","DOIUrl":"10.1016/j.jvsvi.2025.100184","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to provide a comprehensive bibliometric analysis of vascular surgery research from 2000 to 2023, examining trends in publications, key research themes, and international collaboration networks.</div></div><div><h3>Methods</h3><div>A literature search was conducted via Scopus, including English-language articles, reviews, and conference papers published between 2000 and 2023 in 16 key vascular surgery journals. Multiple parameters of the retrieved publications were analyzed, including annual growth, key themes identified through author keyword co-occurrence analysis, productivity and impact of countries, institutions, journals, and authors through citation analysis, and collaborative networks through co-authorship analysis.</div></div><div><h3>Results</h3><div>Our search yielded 43,483 documents with a mean of 23.5 citations per document and an overall <em>h</em>-index of 242. There was a steady increase in annual publications, rising from 1257 documents in 2000 to 2974 in 2023. The predominant research themes identified were abdominal aortic aneurysm (1559 occurrences), peripheral artery/arterial disease (1222 occurrences), and endovascular aneurysm repair (752 occurrences), with additional focus areas including carotid endarterectomy (511 occurrences), and varicose veins (310 occurrences). The <em>Journal of Vascular Surgery</em> emerged as the most prolific journal, publishing 10,760 documents (24.7%) with 430,306 citations (42.1%), followed by the <em>Annals of Vascular Surgery</em> (7464 documents, 17.2%) and the <em>Journal of Vascular and Interventional Radiology</em> (5613 documents, 12.9%). The United States led in research productivity, producing 20,324 documents with 554,038 citations, followed by the United Kingdom (3743 documents and 118,370 citations) and the Netherlands (2220 documents and 71,016 citations). Institutionally, the Department of Vascular Surgery at the Cleveland Clinic Foundation led with 238 documents and 12,784 citations. Furthermore, 14 of the top 20 most productive institutions and all 10 of the top 10 authors with the highest total citation counts were American.</div></div><div><h3>Conclusions</h3><div>This study provides a comprehensive bibliometric analysis of vascular surgery research spanning from 2000 to 2023, revealing substantial growth in publication output and identifying key research themes. The findings underscore the dominant role of the United States in shaping global research collaboration within vascular surgery, as evidenced by its significant contributions in publication volume and citations across national, institutional, and individual authorship domains. These insights provide valuable guidance for future research endeavors aimed at advancing understanding and enhancing the effectiveness of vascular surgery research globally.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100184"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143453328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Where eagles dare","authors":"Nivedita Mitta MBBS, MS, MCh, MRCS,&nbsp;Raghvinder Pal Singh Gambhir MS, DNB, FRCSEd, FFSTEd, FACS, FEBS,&nbsp;Abhilash Sudarsanam MBChB (Hons), MSc, FRCS,&nbsp;Domenico Valenti MBChB (Hons), FRCS(Eng), FRCS(Ed), FEBVS","doi":"10.1016/j.jvsvi.2025.100228","DOIUrl":"10.1016/j.jvsvi.2025.100228","url":null,"abstract":"<div><div>Eagle syndrome is a rare clinical condition that presents with multitude of symptoms, owing to an abnormally elongated/misshapen styloid process. The patients often present to other specialties like otorhinology, oromaxillofacial surgeons, or neurologists rather than vascular surgeons. Our case and the literature review, focuses on the stylocarotid syndrome. Styloidectomy along with corrective carotid surgery, after multidisciplinary consultation, led to resolution of long-standing symptoms in a young patient.</div></div>","PeriodicalId":74034,"journal":{"name":"JVS-vascular insights","volume":"3 ","pages":"Article 100228"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144166693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}